Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Feb 2.
Published in final edited form as: AIDS. 2021 Feb 2;35(2):347–349. doi: 10.1097/QAD.0000000000002723

Outcomes of HIV-exposed but Uninfected Children in South Africa over 5 Years

Mary Jane ROTHERAM-BORUS 2, Adriane WYNN 1,*, Jackie STEWART 3, Ellen ALMIROL 2, Thomas W WEICHLE 2, Julia TUBERT 2, Mark TOMLINSON 3,4
PMCID: PMC7789330  NIHMSID: NIHMS1648559  PMID: 33394675

Expansion of services to prevent mother-to-child transmission of HIV substantially reduced infections among children.[1] However, high maternal HIV prevalence in many countries, such as South Africa (30%), contributes to growing numbers of children exposed to HIV but uninfected (CHEU).[2] Understanding the health status of CHEU is a critical research priority.

Previous studies found CHEU have higher risks for mortality and morbidities compared to unexposed children (CHUU).[3] A recent study in AIDS found infant mortality among CHEU was higher than the national rate and growth rates over 18 months were poor.[4] Given that maternal HIV likely has broad impacts on children’s well-being, we conducted a study with an extended examination of growth, and cognitive and behavioural functioning of CHEU over five years, compared to CHUU in the same communities.

We conducted a retrospective cohort study using data from the Philani+ trial in Cape Town, South Africa. Philani+ methods have been previously described.[5] Between 2009 and 2010, recruiters enrolled pregnant women from 24 neighbourhoods, which were matched and randomized to either an intervention or control group. The intervention group received home visits by paraprofessional community health workers. Health outcomes were collected during pregnancy, at two weeks, and six, 18, 36, and 60 months post-birth. Findings stratified by intervention have been previously reported.[6] There were no significant intervention effects based on maternal HIV status on children’s outcomes, thus we did not include intervention status in these analyses.

Children’s height and weight were measured at each assessment. Growth measures were converted to z-scores.[7] Child Behavior was assessed at 36 months using the Strengths and Difficulties Questionnaire[8] and Child Behavior Checklist (CBCL).[9] Cognitive functioning was assessed at 18 months using the Bayley Scale of Infant Development,[10, 11] 36 and 60 months with the Peabody Picture Vocabulary Test,[12] and 60 months through the Kaufman Assessment Battery for Children.[13] We documented maternal ART use, CHEU NVP receipt, breastfeeding status, child hospitalizations, respiratory disorders, and diarrhoea.

We examined child outcomes by the CHEU and CHUU groups using t-tests and chi-square tests. We used mixed-effects linear regression models with restricted maximum likelihood estimation for continuous outcomes, and mixed-effects logistic and mixed-effects negative binomial regression models for discrete and count outcomes. Models included fixed effects for mother’s HIV status, time point, and an interaction between children’s HIV exposure and time point; and adjustments controlling for children’s age and any breastfeeding.

Table 1 summarizes the differences between CHUE and CHUU children. Our sample included 289 CHEU and 596 CHUU. Among MLH, 78.8% were ever on ART, and among CHUE, 90.9% received NVP, and 95.9% received a PCR HIV test at 6 months. Over five years, 22 mothers and 104 infants died, and mortality did not differ by maternal HIV status. CHEU had similar odds of being admitted to the hospital and acquiring respiratory illnesses or pneumonia compared to CHUU. Diarrhea was more common among CHEU at 6 months, but was more common among CHUU at 5 years. Immunizations were similar.

Table1.

Child outcomes by Children HIV exposed, but uninfected (CHEU) (N=289) and children who are HIV unexposed and uninfected (CHUU) (N=596) up to 5 years

HEU HUU Estimated Odds Ratio HEU vs. HUU
n % n % OR1 95% CI
Growth measures
Low birth weight infant (< 2500 grams)3 34 11.8 53 8.9 0.06a −0.01 – 0.13
Stunted (HAZ < −2 SD) 20 6.9 41 6.9 0.81a,c 0.31 – 2.10
Malnourished (WAZ < −2 SD) 7 2.4 13 2.2 2.40a,c 0.35 – 16.28
Hospitalizations
Admitted to hospital 32 11.1 83 14.1 0.71a,c 0.39 – 1.31
Estimated Mean Difference HEU vs. HUU
Mean SD Mean SD Difference2 95% CI
Growth measures
Height-for-age Z-score (HAZ) −0.56 0.93 −0.51 0.98 −0.04a,b −0.23 – 0.15
Weight-for-age Z-score −0.11 1.00 0.02 0.97 −0.14a,b −0.32 – 0.04
Behavior Outcomes
Strength and Difficulties Questionnaire5 9.58 4.67 9.63 4.65 0.23a −0.87 – 1.33
Child Behavior Checklist
 Aggressive Behavior Subscale Score 10.51 8.19 10.77 8.11 −0.64a,c −2.16 – 0.89
Cognitive Outcomes
Bayley Scale of Infant Development5
 Cognitive Composite Score 100.64 14.58 99.65 13.84 −1.12a −6.46 – 4.23
 Motor Composite Score 103.7 13.53 103.4 12.11 1.46a −3.35 – 6.26
Peabody Picture Vocabulary Test 60.30 16.38 62.63 17.92 −2.47a,c −6.30 – 1.36
Kaufman Assessment
 Global Scale Index (MPI) Standard Score** 81.65 10.96 84.12 11.34 −2.12a −4.70 – 0.46
Hospitalizations
Number of times admitted to hospital 0.15 0.49 0.24 0.74 −0.11a,c −0.24 – 0.03
*

p ≤ 0.05

**

p ≤ 0.01 (t-tests or χ2 tests);

+

p < 0.05 (regression estimates) adjusting for any breastfeeding, up to 18 months

1

Mixed-effects logistic regression for binary outcomes

2

Mixed-effects linear regression for continuous outcomes; Mixed-effects negative binomial regression for count outcomes

3

Measured at post-birth only, N=1001;

4

Measured at 18 Months only, N=503

5

Measured 3-years only, N=896

a

Random-intercept for neighborhood and child (neighborhood random-intercept only for LBW, Immunizations, Bayley, and Kaufman assessment; child random-intercept only for WAZ < −2 SD)

b

Random-slope for time using unstructured covariance structure;

c

Random-slope for time using identity covariance structure

CHEU had lower weight-for-age z-scores (WAZ) than CHUU at post-birth and 18-months, but differences were not significant at other time points. Height-for-age z-score(HAZ) differences were observed at 6 and 18 months, but not at 3 or 5 years. In adjusted analyses, CHEU and CHUU were similar in terms of HAZ, WAZ, low birth weight (<2500mg), stunting (HAZ < −2 SD), and malnourishment (WAZ < −2 SD). There were no significant differences on the Child Behaviour Checklist, Strengths and Difficulties Questionnaire, Bayley Scale of Infant Development, Peabody Picture Vocabulary Test, or Kaufman Assessment.

We found that CHEU were similar to CHUU on health, growth, and cognitive and behavioural functioning over the first five years of life in Cape Town, South Africa. While CHEU experienced lower weight and height at post-birth and 18-month, they were similar to CHUU at 3 and 5-years.

Our findings are consistent with other longer longitudinal studies indicating that differences in growth present in the first year of life and then decrease over time.[14, 15] Further, a South African study found breastfed CHEU had transient increases in morbidity risk between 8 days and 3 months, which were no longer present after 3 months; and infection-related hospitalizations in CHEU with mothers on ART were similar to CHUU.[16]

Despite the challenges faced by mothers living with HIV, health and developmental trajectories of CHEU were similar to CHUU after accounting for ART receipt and breastfeeding. While these data suggest time-limited impact of in-utero HIV exposure, questions remain in terms of impacts in later developmental periods, such as adolescence.

Acknowledgements

MJR, JS, and MT created the study design; EA, TW, and AW were responsible for data analytics; AW, MJR, JS, JT, MT contributed to writing the manuscript.

Conflicts of Interest and Source of Funding. This work was supported by the National Institute on Alcohol Abuse and Alcoholism (R01AA017104, R24AA022919), National Institute of Mental Health (P30MH058107), the UCLA Center for AIDS Research (P30AI028697), the National Center for Advancing Translational Science (UL1TR00188), the Post-doctoral HIV Research Training Program for HIV Combination Prevention (T32MH109205), the UCLA Clinical and Translational Science Institute (UL1TR000124) and the Ilifa Labantwana Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors have no conflicts of interest to report.

Footnotes

Disclosure of Potential Conflicts of Interest. The authors disclose that they have no conflict of interest.

Data sharing and availability plan. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  • 1.Council SANA. South Africa Global AIDS Response Progress Report. In; 2016.
  • 2.UNAIDS. AIDSinfo. In; 2019.
  • 3.Evans C, et al. HIV-exposed, uninfected infants: new global challenges in the era of paediatric HIV elimination. Lancet Infect Dis 2016; 16(6):e92–e107. [DOI] [PubMed] [Google Scholar]
  • 4.Patel MR, et al. HIV-exposed uninfected infant morbidity and mortality within a nationally representative prospective cohort of mother-infant pairs in Zimbabwe. AIDS 2020; 34(9):1339–1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Rotheram-Borus MJ, et al. Philani Plus (+): a Mentor Mother community health worker home visiting program to improve maternal and infants’ outcomes. Prevention science : the official journal of the Society for Prevention Research 2011; 12(4):372–388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.le Roux IM, et al. Outcomes of home visits for pregnant mothers and their infants: a cluster randomized controlled trial. Aids 2013; 27(9):1461–1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.World Health O. WHO Child Growth Standards. In; 2015.
  • 8.Goodman R, et al. The Strengths and Difficulties Questionnaire: a pilot study on the validity of the self-report version. Eur Child Adolesc Psychiatry 1998; 7(3):125–130. [DOI] [PubMed] [Google Scholar]
  • 9.Achenbach T, Edelbrock C. Manual for the Child. Behaviour Checklist/4-r8 and 1991 Profile 1991; (Journal Article). [Google Scholar]
  • 10.Bayley N Bayley Scales of Infant and Toddler Development (Bayley-III). Third Edition ed. San Antonio, TX: The Psychological Corporation; 2005. [Google Scholar]
  • 11.McCoy DC, et al. Development and validation of an early childhood development scale for use in low-resourced settings. Popul Health Metr 2017; 15(1):3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pakendorf C, Alant E. Culturally valid assessment tools: northern Sotho translation of the Peabody Picture Vocabulary Test-Revised. S Afr J Commun Disord 1997; 44:3–12. [PubMed] [Google Scholar]
  • 13.Kaufman AS, Kaufman AL. Kaufman assessment battery for children. John Wiley & Sons, Inc; 1983. [Google Scholar]
  • 14.Wedderburn CJ, et al. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study. The Lancet Child & adolescent health 2019; 3(11):803–813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sugandhi N, et al. HIV-exposed infants: rethinking care for a lifelong condition. AIDS 2013; 27 Suppl 2:S187–195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.le Roux SM, et al. Infectious morbidity of breastfed, HIV-exposed uninfected infants under conditions of universal antiretroviral therapy in South Africa: a prospective cohort study. The Lancet Child & adolescent health 2020; 4(3):220–231. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES